嵌合抗原受体自然杀伤细胞疗法在首次试验中安全有效。 - Suppr

CAR Natural Killer Cell Therapy Safe and Effective in First Trial.

作者信息

Abbasi Jennifer

出版信息

JAMA. 2020 Mar 10;323(10):916. doi: 10.1001/jama.2020.1940.

DOI:10.1001/jama.2020.1940

PMID:32154845

Abstract

摘要

相似文献

CAR Natural Killer Cell Therapy Safe and Effective in First Trial.

JAMA. 2020 Mar 10;323(10):916. doi: 10.1001/jama.2020.1940.

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607.

Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma.

Leukemia. 2020 May;34(5):1291-1304. doi: 10.1038/s41375-019-0663-x. Epub 2019 Nov 26.

Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.

Cytotherapy. 2017 Feb;19(2):235-249. doi: 10.1016/j.jcyt.2016.10.009. Epub 2016 Nov 22.

The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review.

Ann Hematol. 2018 Aug;97(8):1327-1335. doi: 10.1007/s00277-018-3368-8. Epub 2018 May 15.

CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications.

Hum Gene Ther. 2018 May;29(5):559-568. doi: 10.1089/hum.2017.254. Epub 2018 Apr 5.

The use of chimeric antigen T-cell therapy in chronic lymphocytic leukemia.

Clin Adv Hematol Oncol. 2022 Jun;20(6):366-368.

Cellular Immunotherapy in B-Cell Malignancy.

Oncol Res Treat. 2017;40(11):674-681. doi: 10.1159/000481946. Epub 2017 Oct 20.

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.

Mol Ther. 2018 Dec 5;26(12):2727-2737. doi: 10.1016/j.ymthe.2018.09.009. Epub 2018 Sep 13.

Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?

Bone Marrow Transplant. 2021 Apr;56(4):974-977. doi: 10.1038/s41409-020-01099-4. Epub 2020 Nov 10.

引用本文的文献

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies.

Cancers (Basel). 2021 Mar 17;13(6):1363. doi: 10.3390/cancers13061363.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

CAR Natural Killer Cell Therapy Safe and Effective in First Trial.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献